Literature DB >> 22400236

Challenges and future expectations of reversed gene therapy.

Nongyue He1, Xin Zeng, Weida Wang, Kunlong Deng, Yunzhi Pan, Li Xiao, Jia Zhang, Kai Li.   

Abstract

Gene therapy is a genetic intervention used for the prevention or treatment of diseases by targeting selected genes with specific nucleotides. The most common form of gene therapy involves the establishment of a function by transfer of functional genes or correction of mutated genes. In other situations, suppression or abolishment of a function is required in order to balance a complicated regulatory system or to deplete cellular molecules crucial for pathogen infection. The latter in fact employs an opposite strategy compared to those used in classical gene therapy, and can be defined as reversed gene therapy. This paper takes CCR5-based stem cell gene therapy as an example to discuss the challenges and future expectations of reversed gene therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22400236     DOI: 10.1166/jnn.2011.5723

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

Review 1.  Biological and biomedical applications of engineered nucleases.

Authors:  Yunzhi Pan; Li Xiao; Alice S S Li; Xu Zhang; Pierre Sirois; Jia Zhang; Kai Li
Journal:  Mol Biotechnol       Date:  2013-09       Impact factor: 2.695

2.  A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.

Authors:  Mei Lin; Junxing Huang; Xingmao Jiang; Jia Zhang; Hong Yu; Jun Ye; Dongsheng Zhang
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.